Axogen (AXGN) Total Non-Current Liabilities (2017 - 2026)
Axogen (AXGN) posted Total Non-Current Liabilities of $48.5 million for Q2 2026, up 8.81% on a QoQ basis from $44.5 million in Q1 2026, and down 46.8% year-over-year from $91.1 million in Q2 2025.
Analysis
Axogen (AXGN) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Axogen has reported Total Non-Current Liabilities for 10 years, with the latest figure at $48.5 million in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 46.8% year-over-year to $48.5 million in Q2 2026; TTM through Jun 2026 was $48.5 million, a 46.8% decrease from a year earlier, with the FY2025 full-year figure at $89.0 million, down 8.69% from the prior year.
- Total Non-Current Liabilities was $48.5 million for Q2 2026 at Axogen, up from $44.5 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $98.2 million in Q4 2023, with the low at $44.5 million in Q1 2026.
- Average Total Non-Current Liabilities over 5 years is $86.1 million, with a median of $90.0 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities rose 18.26% in 2022, then tumbled 49.53% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $89.9 million in 2022, then climbed by 9.24% to $98.2 million in 2023, then retreated by 0.77% to $97.4 million in 2024, then decreased by 8.69% to $89.0 million in 2025, then slumped by 45.52% to $48.5 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $48.5 million (Q2 2026), $44.5 million (Q1 2026), and $89.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Axogen | 2.51 Bn | 2.40 Bn | 50.67 Mn | 48.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.47 Mn |
| Mar 31, 2026 | 44.54 Mn |
| Dec 31, 2025 | 88.95 Mn |
| Sep 30, 2025 | 93.73 Mn |
| Jun 30, 2025 | 91.10 Mn |
| Mar 31, 2025 | 88.24 Mn |
| Dec 31, 2024 | 97.42 Mn |
| Sep 30, 2024 | 90.13 Mn |
| Jun 30, 2024 | 90.79 Mn |
| Mar 31, 2024 | 90.44 Mn |
| Dec 31, 2023 | 98.18 Mn |
| Sep 30, 2023 | 92.95 Mn |
| Jun 30, 2023 | 90.22 Mn |
| Mar 31, 2023 | 87.26 Mn |
| Dec 31, 2022 | 89.87 Mn |
| Sep 30, 2022 | 89.67 Mn |
| Jun 30, 2022 | 89.52 Mn |
| Mar 31, 2022 | 88.86 Mn |
| Dec 31, 2021 | 89.91 Mn |
| Sep 30, 2021 | 90.87 Mn |